Solentim Company

Automated single cell cloning, cell culture. Solentim is a trusted global leader for solutions to create, isolate, and characterize the highest value cells for the development of new biological medicines, including cell and gene therapies, monoclonal antibodies, vaccines and stem cells. For our customers, which include most of the world’s leading pharmaceutical and biotherapeutics companies, we are the partner of choice for facilitating the highest level of assurance in cell line development for therapeutic protein and viral vector production.
Technology: AgeTech Companies
Industry: Covid-19
Headquarters: United Kingdom
Founded Date: 2010
Employees Number: 11-50
Funding Status: N/A
Estimated Revenue: Less than $1M

Visit Website
Register and Claim Ownership